Tesamorelin
GHRH analogue · visceral fat reduction · IGF-1 elevation
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) approved for HIV-related lipodystrophy. Research shows significant visceral fat reduction and elevated IGF-1.
For research use only. Not for human consumption.
Volume pricingper vial
| 1 vial | €39.90 |
| 10+ vials | — |
| 50+ vials | — |
| 100+ vials | — |
For laboratory research use only. Not for human or veterinary consumption.
Order
Quantity (vials)
Tier price applies based on total vial count. For laboratory research use only.
More in Peptide
Peptide
AM5
5-Amino-1MQ
Mitochondrial activator · NNMT inhibitor · metabolic optimization
€34.90/ vial
Peptide
BP10
BPC-157
Body-protective compound · gut & tissue healing · recovery
€32.90/ vial
Peptide
CJI10
CJC-1295 + Ipamorelin
Synergistic GHRH + GHS blend · pulsatile GH release
€39.90/ vial
Peptide
EPI10
Epithalon
Telomere elongation · anti-ageing · pineal peptide
€29.90/ vial